Publications

Year of Publication Titlesort descending Faculty Association
2023 Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance. Edita Navratilova, Frank Porreca, PhD
2022 Conotoxin contulakin-G engages a neurotensin receptor 2/R-type calcium channel (Cav2.3) pathway to mediate spinal antinociception. Mohab M. Ibrahim, PhD, MD, Laurent F Martin, Tally Largent-Milnes, PhD, Frank Porreca, PhD
2018 Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2022 Contributions of sex and genotype to exploratory behavior differences in an aged humanized mouse model of late-onset Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2015 CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.
2022 Cutaneous heat and light-induced pain thresholds in post-traumatic headache attributed to mild traumatic brain injury. Frank Porreca, PhD
2016 Cyclic non-opioid dynorphin A analogues for the bradykinin receptors. Frank Porreca, PhD
2016 Cyclic Opioid Peptides.
2020 DAGLα Inhibition as a Non-invasive and Translational Model of Episodic Headache. Kelly L Karlage, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2010 Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence. Roberta Diaz Brinton, Ph.D
2021 Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain. Edita Navratilova, Frank Porreca, PhD
2015 Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2022 Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery. Sally Dickinson, Ph.D.
2015 Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs.
1995 Detecting differences in 5-methylcytosine using restriction enzyme isoschizomers: an endogenous control for complete digestion.
2019 Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light. Mohab M. Ibrahim, PhD, MD, Frank Porreca, PhD, Todd Vanderah, PhD
2023 Development and evaluation of a pre-clerkship spiral curriculum: data from three medical school classes. Todd Vanderah, PhD
2002 Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate.
2020 Development of 3D Printed Drug-Eluting Scaffolds for Preventing Piercing Infection. Christopher Cartmell
2021 Development of a microbe domestication pod (MD Pod) for in situ cultivation of micro-encapsulated marine bacteria. Christopher Cartmell
2013 Development of functionally selective, small molecule agonists at kappa opioid receptors. John M. Streicher, PhD
2021 Development of N,O-Carboxymethyl Chitosan-Starch Biomaterial Inks for 3D Printed Wound Dressing Applications. Christopher Cartmell
2011 Development of potent μ and δ opioid agonists with high lipophilicity. Frank Porreca, PhD, Todd Vanderah, PhD
2008 Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells.
2014 Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides.

Pages